Biogen And Eisai Say Alzheimer’s Drug A Success, Encouraging Phase II Results in Alzheimer’s Disease
A complicated new clinical trial could give some hope to Alzheimer’s patients and investors in drug companies. But there are [...]
A complicated new clinical trial could give some hope to Alzheimer’s patients and investors in drug companies. But there are [...]